
Sharon M. Moe, MD
Associate Dean for Clinical and Translational Research
Bio
Sharon M. Moe, MD, is the Associate Dean for Clinical and Translational Research, and the Co-Director for the Indiana Clinical Translational Sciences Institute. She is also Director of the Division of Nephrology and Stuart A. Kleit Professor of Medicine for the Indiana University School of Medicine. She has been a faculty member at Indiana University since 1992, and in 2019 was named Distinguished Professor at IU. Dr. Moe is the principal investigator for several ongoing basic and clinical research studies in the field of Chronic Kidney Disease -Mineral Bone Disorder (CKD-MBD), including studies on vascular calcification, mineral metabolism and bone metabolism in kidney disease. Her research has been funded by the NIH and Veterans Affairs for over 20 years, in addition to funding from foundations and pharmaceutical companies. She has authored over 200 scientific manuscripts, teaching manuscripts and textbook chapters and has mentored over 25 pre/post docs and clinical fellows on NIH awards. Dr. Moe served on the National Kidney Foundation’s Bone and Mineral metabolism K/DOQI clinical practice guidelines in 2003, was co-chair of the international KDIGO Mineral and Bone guidelines released in 2009, and a member of the 2017 update committee. She has serves on numerous ad hoc NIH study sections, and was recently named as a standing member to the AMSC study section. Key Honors include election to the American Society for Clinical Research in 2005; the National Kidney Foundation in Gareb Eknoyan Award for exceptional contributions to key initiatives of the such as the Kidney Disease Outcomes Quality Initiative (KDOQI) in 2009; Councilor to the AHA Kidney Council (2002-2004), Councilor for the International Society of Nephrology (2005-2007), Councilor for the American Society of Nephrology from 2008- 2015; President of the American Society of Nephrology from 2013-2014, and election to the American Association of Physicians (AAP) in 2017.
Titles & Appointments
- Associate Dean for Clinical and Translational Research
- Co-Director of Clinical and Translational Sciences Institute
- Distinguished Professor
- Stuart A. Kleit Professor of Nephrology
- Professor of Medicine
- Adjunct Professor of Anatomy, Cell Biology & Physiology
- Division Chief
- Division Chief
- Adjunct Professor for Anatomy and Cell Biology
-
Education1992 FEL Postdoctoral Research Fellow, Department of Medicine, Section of Nephrology, University of Chicago, Chicago, IL1990 FEL Nephrology Clinical Fellow , Department of Medicine, Section of Nephrology, University of Chicago, Chicago, IL1989 RES Internal Medicine Resident, Loyola University Medical Center, Maywood, IL1986 MD University of Illinois1982 BS University of Illinois
-
Research
My research investigates the relationship of kidney disease, vascular calcification, bone, and disorders of mineral metabolism known as CKD-Mineral Bone Disorder (CKD-MBD). Our research is funded by the NIH, Veterans Administration, Food and Drug Administration, and industry and utilizes in vivo, ex vivo and in vitro techniques to investigate the pathophysiology of arterial medial calcification and bone disease. We are using a naturally occurring rat model of CKD that spontaneously develops all manifestations of CKD-MBD to study 1) mechanisms by which matrix vesicles propagate arterial calcification, 2) how oxidative stress alters vasculature, 3) the role of advanced glycation end product cross linking of bone collagen predisposes to fracture, 4) mechanisms of sudden cardiac death, 5) how impaired muscle function occurs with progressive CKD, and 6) micro RNA as biomarkers. We also have active investigator initiated clinical trials studying the natural progression of frailty and muscle weakness in patients as they start on dialysis, novel phosphate binders and the effect on phosphate balance, how nutrition can be enhanced in patients on dialysis, and the use of pioglitazone as a treatment for ADPKD.
-
PublicationsVoluntary Wheel Running Has Beneficial Effects in a Rat Model of CKD-Mineral Bone Disorder (CKD-MBD).
Avin KG; Allen MR; Chen NX; Srinivasan S; O'Neill KD; Troutman AD; Mast G; Swallow EA; Brown MB; Wallace JM; Zimmers TA; Warden SJ; Moe SM; Journal of the American Society of Nephrology : JASN 2019 Sep 9Increasing Nephrologist Awareness of Symptom Burden in Older Hospitalized End-Stage Renal Disease Patients.
Jawed A; Moe SM; Moorthi RN; Torke AM; Eadon MT; American journal of nephrology 2019 Nov 19Kidney Disease Progression Does Not Decrease Intestinal Phosphorus Absorption in a Rat Model of Chronic Kidney Disease-Mineral Bone Disorder.
Vorland CJ; Biruete A; Lachcik PJ; Srinivasan S; Chen NX; Moe SM; Hill Gallant KM; Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2019 Nov 15Parathyroid suppression therapy normalizes chronic kidney disease-induced elevations in cortical bone vascular perfusion: a pilot study.
Aref MW; Swallow EA; Metzger CE; Chen N; Moe SM; Allen MR; Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2019 May 8Time course of rapid bone loss and cortical porosity formation observed by longitudinal µCT in a rat model of CKD.
McNerny EMB; Buening DT; Aref MW; Chen NX; Moe SM; Allen MR; Bone 2019 May 3Effect of ovariectomy on the progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in female Cy/+ rats.
Vorland CJ; Lachcik PJ; Swallow EA; Metzger CE; Allen MR; Chen NX; Moe SM; Hill Gallant KM; Scientific reports 2019 May 28Phosphate Binders and Nonphosphate Effects in the Gastrointestinal Tract.
Biruete A; Hill Gallant KM; Lindemann SR; Wiese GN; Chen NX; Moe SM; Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2019 Mar 4Characterizing Dysgeusia in Hemodialysis Patients.
Fitzgerald C; Wiese G; Moorthi RN; Moe SM; Hill Gallant K; Running CA; Chemical senses 2019 Mar 11Skeletal levels of bisphosphonate in the setting of chronic kidney disease are independent of remodeling rate and lower with fractionated dosing.
Swallow EA; Aref MW; Metzger CE; Sacks S; Lehmkuhler DR; Chen N; Hammond MA; Territo PR; Nickolas TL; Moe SM; Allen MR; Bone 2019 Jul 9Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis.
Schwantes-An TH; Liu S; Stedman M; Decker BS; Wetherill L; Edenberg HJ; Vatta M; Foroud TM; Chertow GM; Moe SM; American journal of nephrology 2019 Jan 22Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD.
Clinkenbeard EL; Noonan ML; Thomas JC; Ni P; Hum JM; Aref M; Swallow EA; Moe SM; Allen MR; White KE; JCI insight 2019 Feb 21Comparison of Risk Factors for Pediatric Kidney Stone Formation: The Effects of Sex.
Schwaderer AL; Raina R; Khare A; Safadi F; Moe SM; Kusumi K; Frontiers in pediatrics 2019 Feb 12Effect of Advanced Glycation End-Products (AGE) Lowering Drug ALT-711 on Biochemical, Vascular, and Bone Parameters in a Rat Model of CKD-MBD.
Chen NX; Srinivasan S; O'Neill K; Nickolas TL; Wallace JM; Allen MR; Metzger CE; Creecy A; Avin KG; Moe SM; Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2019 Dec 30Tester and testing procedure influence clinically determined gait speed.
Warden SJ; Kemp AC; Liu Z; Moe SM; Gait & posture 2019 Aug 28Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis.
Wolf M; Block GA; Chertow GM; Cooper K; Fouqueray B; Moe SM; Sun Y; Tomlin H; Vervloet M; Oberbauer R; Clinical kidney journal 2019 Apr 26Effect of dietary phosphorus intake and age on intestinal phosphorus absorption efficiency and phosphorus balance in male rats.
Vorland CJ; Lachcik PJ; Aromeh LO; Moe SM; Chen NX; Hill Gallant KM; PloS one 2018 Nov 19Matrix vesicles induce calcification of recipient vascular smooth muscle cells through multiple signaling pathways.
Chen NX; O'Neill KD; Moe SM; Kidney international 2017 Oct 9Calcium-Sensing Receptor Genotype and Response to Cinacalcet in Patients Undergoing Hemodialysis.
Moe SM; Wetherill L; Decker BS; Lai D; Abdalla S; Long J; Vatta M; Foroud TM; Chertow GM; Clinical journal of the American Society of Nephrology : CJASN 2017 Jun 19Renal Osteodystrophy or Kidney-Induced Osteoporosis?
Moe SM; Current osteoporosis reports 2017 JunMoving Beyond the Assumed: Improving Fistula Success Rates.
Wish JB; Moe SM; Journal of the American Society of Nephrology : JASN 2017 Jul 21Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.
Ketteler M; Block GA; Evenepoel P; Fukagawa M; Herzog CA; McCann L; Moe SM; Shroff R; Tonelli MA; Toussaint ND; Vervloet MG; Leonard MB; Kidney international 2017 JulEffect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials.
Block GA; Bushinsky DA; Cunningham J; Drueke TB; Ketteler M; Kewalramani R; Martin KJ; Mix TC; Moe SM; Patel UD; Silver J; Spiegel DM; Sterling L; Walsh L; Chertow GM; JAMA 2017 Jan 10Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
Block GA; Bushinsky DA; Cheng S; Cunningham J; Dehmel B; Drueke TB; Ketteler M; Kewalramani R; Martin KJ; Moe SM; Patel UD; Silver J; Sun Y; Wang H; Chertow GM; JAMA 2017 Jan 10Calcium Homeostasis in Health and in Kidney Disease.
Moe SM; Comprehensive Physiology 2016 Sep 15Fractures in Patients with CKD: Time for Action.
Moe SM; Nickolas TL; Clinical journal of the American Society of Nephrology : CJASN 2016 Oct 24Intracellular calcium increases in vascular smooth muscle cells with progression of chronic kidney disease in a rat model.
Rodenbeck SD; Zarse CA; McKenney-Drake ML; Bruning RS; Sturek M; Chen NX; Moe SM; Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2016 Aug 9Skeletal Muscle Regeneration and Oxidative Stress Are Altered in Chronic Kidney Disease.
Avin KG; Chen NX; Organ JM; Zarse C; O'Neill K; Conway RG; Konrad RJ; Bacallao RL; Allen MR; Moe SM; PloS one 2016 Aug 3Calcium as a cardiovascular toxin in CKD-MBD.
Moe SM; Bone 2016 Aug 27Reduced skeletal muscle function is associated with decreased fiber cross-sectional area in the Cy/+ rat model of progressive kidney disease.
Organ JM; Srisuwananukorn A; Price P; Joll JE; Biro KC; Rupert JE; Chen NX; Avin KG; Moe SM; Allen MR; Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2015 Oct 5Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease.
Newman CL; Creecy A; Granke M; Nyman JS; Tian N; Hammond MA; Wallace JM; Brown DM; Chen N; Moe SM; Allen MR; Kidney international 2015 Oct 21Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial.
Pun PH; Abdalla S; Block GA; Chertow GM; Correa-Rotter R; Dehmel B; Drüeke TB; Floege J; Goodman WG; Herzog CA; London GM; Mahaffey KW; Moe SM; Parfrey PS; Wheeler DC; Middleton JP; Hemodialysis international. International Symposium on Home Hemodialysis 2015 Nov 13Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy.
Moe SM; Chen NX; Newman CL; Organ JM; Kneissel M; Kramer I; Gattone VH 2nd; Allen MR; Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2015 MarASN Presidential Address 2014: Moving Past Nephrology's Midlife Crisis.
Moe SM; Journal of the American Society of Nephrology : JASN 2015 Jan 29The effect of a diet containing 70% protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease.
Moorthi RN; Armstrong CL; Janda K; Ponsler-Sipes K; Asplin JR; Moe SM; American journal of nephrology 2015 Jan 20Bone marrow fat is increased in chronic kidney disease by magnetic resonance spectroscopy.
Moorthi RN; Fadel W; Eckert GJ; Ponsler-Sipes K; Moe SM; Lin C; Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2015 Feb 21The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
Parfrey PS; Drüeke TB; Block GA; Correa-Rotter R; Floege J; Herzog CA; London GM; Mahaffey KW; Moe SM; Wheeler DC; Kubo Y; Dehmel B; Goodman WG; Chertow GM; for the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators; Clinical journal of the American Society of Nephrology : CJASN 2015 Feb 20Subcutaneous nerve activity and mechanisms of sudden death in a rat model of chronic kidney disease.
Zhao Y; Chen NX; Shirazi JT; Shen C; Lin SF; Fishbein MC; Moe SM; Chen PS; Heart rhythm : the official journal of the Heart Rhythm Society 2015 Dec 29Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial.
Wheeler DC; London GM; Parfrey PS; Block GA; Correa-Rotter R; Dehmel B; Drüeke TB; Floege J; Kubo Y; Mahaffey KW; Goodman WG; Moe SM; Trotman ML; Abdalla S; Chertow GM; Herzog CA; EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial Investigators; Journal of the American Heart Association 2014 Nov 17Pathogenesis of arrhythmias in a model of CKD.
Hsueh CH; Chen NX; Lin SF; Chen PS; Gattone VH 2nd; Allen MR; Fishbein MC; Moe SM; Journal of the American Society of Nephrology : JASN 2014 May 22Adipocyte induced arterial calcification is prevented with sodium thiosulfate.
Chen NX; O'Neill K; Akl NK; Moe SM; Biochemical and biophysical research communications 2014 May 10Cortical bone mechanical properties are altered in an animal model of progressive chronic kidney disease.
Newman CL; Moe SM; Chen NX; Hammond MA; Wallace JM; Nyman JS; Allen MR; PloS one 2014 Jun 9Nicotinamide treatment in a murine model of familial tumoral calcinosis reduces serum Fgf23 and raises heart calcium.
Reilly AM; Gray AK; Moe SM; Ichikawa S; Bone 2014 Jul 4Changes in skeletal collagen cross-links and matrix hydration in high- and low-turnover chronic kidney disease.
Allen MR; Newman CL; Chen N; Granke M; Nyman JS; Moe SM; Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2014 Dec 3Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial.
Moe SM; Abdalla S; Chertow GM; Parfrey PS; Block GA; Correa-Rotter R; Floege J; Herzog CA; London GM; Mahaffey KW; Wheeler DC; Dehmel B; Goodman WG; Drüeke TB; for the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators; Journal of the American Society of Nephrology : JASN 2014 Dec 11A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD.
Moe SM; Chen NX; Newman CL; Gattone VH 2nd; Organ JM; Chen X; Allen MR; Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2014 AprAdverse mandibular bone effects associated with kidney disease are only partially corrected with bisphosphonate and/or calcium treatment.
Allen MR; Chen NX; Gattone VH 2nd; Moe SM; American journal of nephrology 2013 Nov 22What have we learned about chronic kidney disease-mineral bone disorder from the EVOLVE and PRIMO trials?
Moe SM; Thadhani R; Current opinion in nephrology and hypertension 2013 NovDecreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD).
Chen NX; Kiattisunthorn K; O'Neill KD; Chen X; Moorthi RN; Gattone VH 2nd; Allen MR; Moe SM; PloS one 2013 May 22Recent advances in the noninvasive diagnosis of renal osteodystrophy.
Moorthi RN; Moe SM; Kidney international 2013 Jun 26Transglutaminase 2 accelerates vascular calcification in chronic kidney disease.
Chen NX; O'Neill K; Chen X; Kiattisunthorn K; Gattone VH; Moe SM; American journal of nephrology 2013 Feb 28Hemodialysis does not alter in vitro hepatic CYP3A4 and CYP2D6 metabolic activity in uremic serum.
Decker BS; O'Neill KD; Chambers MA; Slaven JE; Yu Z; Jones DR; Moe SM; Clinical pharmacology : advances and applications 2013 Dec 10Worsening endothelial function with efavirenz compared to protease inhibitors: a 12-month prospective study.
Gupta SK; Shen C; Moe SM; Kamendulis LM; Goldman M; Dubé MP; PloS one 2012 Sep 20Vascular calcification: pathophysiology and risk factors.
Chen NX; Moe SM; Current hypertension reports 2012 JunGentamicin pharmacokinetics and pharmacodynamics during short-daily hemodialysis.
Decker BS; Mohamed AN; Chambers M; Kraus MA; Moe SM; Sowinski KM; American journal of nephrology 2012 Jul 18Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease.
Hill KM; Martin BR; Wastney ME; McCabe GP; Moe SM; Weaver CM; Peacock M; Kidney international 2012 Dec 19Skeletal effects of zoledronic acid in an animal model of chronic kidney disease.
Allen MR; Chen NX; Gattone VH 2nd; Chen X; Carr AJ; LeBlanc P; Brown D; Moe SM; Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2012 Aug 21CKD-mineral and bone disorder: core curriculum 2011.
Moorthi RN; Moe SM; American journal of kidney diseases : the official journal of the National Kidney Foundation 2011 Oct 21The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat.
Moe SM; Radcliffe JS; White KE; Gattone VH 2nd; Seifert MF; Chen X; Aldridge B; Chen NX; Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2011 NovCalcimimetics inhibit renal pathology in rodent nephronophthisis.
Chen NX; Moe SM; Eggleston-Gulyas T; Chen X; Hoffmeyer WD; Bacallao RL; Herbert BS; Gattone VH 2nd; Kidney international 2011 Jun 1Efficacy of sodium thiosulfate for the treatment for calciphylaxis.
Noureddine L; Landis M; Patel N; Moe SM; Clinical nephrology 2011 JunActivation of arterial matrix metalloproteinases leads to vascular calcification in chronic kidney disease.
Chen NX; O'Neill KD; Chen X; Kiattisunthorn K; Gattone VH; Moe SM; American journal of nephrology 2011 Jul 23Optimal vitamin D, calcitriol, and vitamin D analog replacement in chronic kidney disease: to D or not to D: that is the question.
Moorthi RN; Kandula P; Moe SM; Current opinion in nephrology and hypertension 2011 JulConfusion on the complexity of calcium balance.
Moe SM; Seminars in dialysis 2010 SepVancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis.
Decker BS; Kays MB; Chambers M; Kraus MA; Moe SM; Sowinski KM; Clinical journal of the American Society of Nephrology : CJASN 2010 Jul 8RhoA/Rho kinase (ROCK) alters fetuin-A uptake and regulates calcification in bovine vascular smooth muscle cells (BVSMC).
Chen NX; Chen X; O'Neill KD; Atkinson SJ; Moe SM; American journal of physiology. Renal physiology 2010 Jul 7A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease.
Moe SM; Saifullah A; LaClair RE; Usman SA; Yu Z; Clinical journal of the American Society of Nephrology : CJASN 2010 Jan 7Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease.
Moe SM; Zidehsarai MP; Chambers MA; Jackman LA; Radcliffe JS; Trevino LL; Donahue SE; Asplin JR; Clinical journal of the American Society of Nephrology : CJASN 2010 Dec 23Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis.
Noureddine LA; Usman SA; Yu Z; Moorthi RN; Moe SM; American journal of nephrology 2010 Aug 16Calcimimetic inhibits late-stage cyst growth in ADPKD.
Gattone VH 2nd; Chen NX; Sinders RM; Seifert MF; Duan D; Martin D; Henley C; Moe SM; Journal of the American Society of Nephrology : JASN 2009 May 7R-568 reduces ectopic calcification in a rat model of chronic kidney disease-mineral bone disorder (CKD-MBD).
Moe SM; Seifert MF; Chen NX; Sinders RM; Chen X; Duan D; Henley C; Martin D; Gattone VH 2nd; Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009 Mar 3Medication changes based on echocardiography in dialysis patients.
Chong CK; Muzoora M; Eckert GJ; Kamalesh M; Moe SM; Hemodialysis international. International Symposium on Home Hemodialysis 2009 Jun 22Review article: Chronic kidney disease-mineral bone disorder: have we got the assays right?
Zidehsarai MP; Moe SM; Nephrology (Carlton, Vic.) 2009 JunVerapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells.
Chen NX; Kircelli F; O'Neill KD; Chen X; Moe SM; Kidney international 2009 Dec 16A rat model of chronic kidney disease-mineral bone disorder.
Moe SM; Chen NX; Seifert MF; Sinders RM; Duan D; Chen X; Liang Y; Radcliff JS; White KE; Gattone VH 2nd; Kidney international 2008 Sep 17Improving global outcomes in mineral and bone disorders.
Moe SM; Drüeke T; Clinical journal of the American Society of Nephrology : CJASN 2008 NovAnnexin-mediated matrix vesicle calcification in vascular smooth muscle cells.
Chen NX; O'Neill KD; Chen X; Moe SM; Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2008 NovPrecision of biomarkers to define chronic inflammation in CKD.
LaClair R; O'Neal K; Ofner S; Sosa MJ; Labarrere CA; Moe SM; American journal of nephrology 2008 May 28Disorders involving calcium, phosphorus, and magnesium.
Moe SM; Primary care 2008 JunAssociation of hepatitis C virus infection with prevalence and development of kidney disease.
Moe SM; Pampalone AJ; Ofner S; Rosenman M; Teal E; Hui SL; American journal of kidney diseases : the official journal of the National Kidney Foundation 2008 Apr 28Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN; Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007 Jul 10Chronic kidney disease-mineral-bone disorder: a new paradigm.
Moe SM; Drüeke T; Lameire N; Eknoyan G; Advances in chronic kidney disease 2007 JanMechanisms of vascular calcification in chronic kidney disease.
Moe SM; Chen NX; Journal of the American Society of Nephrology : JASN 2007 Dec 19Vitamin D, cardiovascular disease, and survival in dialysis patients.
Moe SM; Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2007 DecHigh glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells.
Chen NX; Duan D; O'Neill KD; Moe SM; Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006 Sep 27Fetuin-A uptake in bovine vascular smooth muscle cells is calcium dependent and mediated by annexins.
Chen NX; O'Neill KD; Chen X; Duan D; Wang E; Sturek MS; Edwards JM; Moe SM; American journal of physiology. Renal physiology 2006 Sep 12Uremic vascular calcification.
Chen NX; Moe SM; Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2006 NovVascular calcification: Hardening of the evidence.
Moe SM; Kidney international 2006 NovFish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis.
Friedman AN; Moe SM; Perkins SM; Li Y; Watkins BA; American journal of kidney diseases : the official journal of the National Kidney Foundation 2006 JunThe mechanisms of uremic serum-induced expression of bone matrix proteins in bovine vascular smooth muscle cells.
Chen NX; Duan D; O'Neill KD; Wolisi GO; Koczman JJ; Laclair R; Moe SM; Kidney international 2006 Jul 12Vascular calcification and renal osteodystrophy relationship in chronic kidney disease.
Moe SM; European journal of clinical investigation 2006 AugThe case against calcium-based phosphate binders.
Moe SM; Chertow GM; Clinical journal of the American Society of Nephrology : CJASN 2006 Apr 26Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States.
LaClair RE; Hellman RN; Karp SL; Kraus M; Ofner S; Li Q; Graves KL; Moe SM; American journal of kidney diseases : the official journal of the National Kidney Foundation 2005 JunRole of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD).
Moe SM; Reslerova M; Ketteler M; O'neill K; Duan D; Koczman J; Westenfeld R; Jahnen-Dechent W; Chen NX; Kidney international 2005 JunLong-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.
Moe SM; Cunningham J; Bommer J; Adler S; Rosansky SJ; Urena-Torres P; Albizem MB; Guo MD; Zani VJ; Goodman WG; Sprague SM; Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005 Jul 19The role of vitamin D in vascular calcification in chronic kidney disease.
Wolisi GO; Moe SM; Seminars in dialysis 2005 Jul[Vascular calcification in end stage renal disease].
Moe SM; Chen NX; Clinical calcium 2002 OctMechanisms of disposal of acid and alkali in rabbit duodenum.
Fiddian-Green RG; Silen W; The American journal of physiology 1975 Dec -
Professional OrganizationsAmerican College of PhysiciansAmerican Medical AssociationAmerican Society for Clinical Investigation
-
Board CertificationsAmerican Board of Internal Medicine - NephrologyAmerican Board of Internal Medicine - Internal Medicine
-
Clinical Interests
My clinical interests focus on the prevention and treatment of kidney stones using diet and medications. In addition I specialize in the treatment of bone disease in patients with kidney disease, and disorders of magnesium and calcium.
-
AwardsOrg: Indiana University
Desc: Bicentennial Medal
Scope: University
Date: 1905-07-14
Org: Indiana University
Desc: Distinguished Professor
Scope: University
Date: 1905-07-13
Org: American Association of Physicians (AAP)
Desc: Elected Member
Scope: National
Date: 1905-07-11
Org: National Kidney Foundation
Desc: Gareb Eknoyan Award, exceptional contributions to key initiatives
Scope: National
Date: 1905-07-03
Org: The American Society for Clinical Investigation
Desc: Elected Member
Scope: National
Date: 1905-06-29
Org: American Heart Association
Desc: Councilor to Kidney Council
Scope: National
Date:
Org: American Society of Nephrology
Desc: Councilor
Scope: National
Date:
Org: American Society of Nephrology
Desc: President
Scope: National
Date:
Org: International Society of Nephrology
Desc: Councilor
Scope: International
Date: